Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Massimo Cugno

Showing results (141-150 of 147) with videos related to

Pageof 15
Sort By:
You have reached the last page of results.This site can display upto 147 results.
Vaccines|September 28, 2021
Increased Risk of Urticaria/Angioedema after BNT162b2 mRNA COVID-19 Vaccine in Health Care Workers Taking ACE InhibitorsMassimo Cugno, Dario Consonni, Andrea Lombardi, et al.
Kidney International Reports|June 25, 2021
Risk of Atypical HUS Among Family Members of Patients Carrying Complement Regulatory Gene AbnormalityGianluigi Ardissino, Selena Longhi, Luigi Porcaro, et al.
La Medicina Del Lavoro|December 23, 2021
Side effects among healthcare workers from a large Milan university hospital after second dose of BNT162b2 mRNA COVID-19 vaccineElisa Borroni, Dario Consonni, Massimo Cugno, et al.
Journal of Nephrology|May 6, 2021
Kidney transplant in patients with atypical hemolytic uremic syndrome in the anti-C5 era: single-center experience with tailored EculizumabGianluigi Ardissino, Donata Cresseri, Francesca Tel, et al.
Thrombosis and Haemostasis|December 29, 2021
Gene Abnormalities in Transplant Associated-Thrombotic Microangiopathy: Comparison between Recipient and Donor's DNAEvangeline Millicent Rodrigues, Gianluigi Ardissino, Giulia Pintarelli, et al.
Journal of Autoimmunity|November 3, 2020
Complement activation and endothelial perturbation parallel COVID-19 severity and activityMassimo Cugno, Pier Luigi Meroni, Roberta Gualtierotti, et al.
American Journal of Human Genetics|September 22, 2005
A variant in XPNPEP2 is associated with angioedema induced by angiotensin I-converting enzyme inhibitorsQing Ling Duan, Borzoo Nikpoor, Marie-Pierre Dube, et al.
Pageof 15

Showing results (141-150 of 147) with videos related to

Sort By:
Pageof 15
You have reached the last page of results.This site can display upto 147 results.
Vaccines|September 28, 2021
Increased Risk of Urticaria/Angioedema after BNT162b2 mRNA COVID-19 Vaccine in Health Care Workers Taking ACE InhibitorsMassimo Cugno, Dario Consonni, Andrea Lombardi, et al.
Kidney International Reports|June 25, 2021
Risk of Atypical HUS Among Family Members of Patients Carrying Complement Regulatory Gene AbnormalityGianluigi Ardissino, Selena Longhi, Luigi Porcaro, et al.
La Medicina Del Lavoro|December 23, 2021
Side effects among healthcare workers from a large Milan university hospital after second dose of BNT162b2 mRNA COVID-19 vaccineElisa Borroni, Dario Consonni, Massimo Cugno, et al.
Journal of Nephrology|May 6, 2021
Kidney transplant in patients with atypical hemolytic uremic syndrome in the anti-C5 era: single-center experience with tailored EculizumabGianluigi Ardissino, Donata Cresseri, Francesca Tel, et al.
Thrombosis and Haemostasis|December 29, 2021
Gene Abnormalities in Transplant Associated-Thrombotic Microangiopathy: Comparison between Recipient and Donor's DNAEvangeline Millicent Rodrigues, Gianluigi Ardissino, Giulia Pintarelli, et al.
Journal of Autoimmunity|November 3, 2020
Complement activation and endothelial perturbation parallel COVID-19 severity and activityMassimo Cugno, Pier Luigi Meroni, Roberta Gualtierotti, et al.
American Journal of Human Genetics|September 22, 2005
A variant in XPNPEP2 is associated with angioedema induced by angiotensin I-converting enzyme inhibitorsQing Ling Duan, Borzoo Nikpoor, Marie-Pierre Dube, et al.
Pageof 15